CymitQuimica logo

(Tyr5·12,Lys7)-Polyphemusin II

CAS:

Ref. 3D-FT108745

1mg
951.00€
2mg
1,558.00€
100µg
199.00€
250µg
376.00€
500µg
580.00€
(Tyr5·12,Lys7)-Polyphemusin II
Biosynth

Product Information

Name:(Tyr5·12,Lys7)-Polyphemusin II
Synonyms:
  • H-Arg-Arg-Trp-Cys-Tyr-Arg-Lys-Cys-Tyr-Lys-Gly-Tyr-Cys-Tyr-Arg-Lys-Cys-Arg-NH2 H-RRWCYRKCYKGYCYRKCR-NH2
Brand:Biosynth
Description:T22 peptide, also known as [Tyr5,12,Lys7]-polyphemusin II peptide, is a short, positively charged peptide, analog of polyphemusin peptide which exerts a strong anti- HIV activity. Polyphemusins are known to inhibit the growth of gram-negative bacteria and some fungi such as Candida Albicans. T22 is a potent antagonist of CXCR4 (IC50 = 5.05 nM), a co-receptor used by HIV to penetrate cells.It has been suggested that T22 exerts its effect against HIV-1 especially by blocking virus-cell fusion and that T22 might interact with HIV envelope protein (such as gp120 ) and T-cell surface protein. T22 antiviral activity has been shown on HIV-infected MT-4 cells with an IC50 of 0.008 µg/mL (2.6 nM). The cytotoxic concentration on HIV virus (CC50) of T22 is 54 µg/mL (17 mM).
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:2,486.98 g/mol
Formula:C109H164N38O22S4
Purity:Min. 95%

Technical inquiry about: (Tyr5·12,Lys7)-Polyphemusin II

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.